We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBLI:NASDAQGlobal Indemnity Group, LLC Analysis

Data as of 2026-04-05 - not real-time

$27.55

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Global Indemnity Group (GBLI) is trading at $27.55, barely above its calculated support of $26.91 and below the 20‑day SMA of 28.32, indicating limited upside in the near term. Technical indicators are bearish – the MACD histogram is negative, the 14‑day RSI sits at 43, and volume trends are decreasing, all pointing to continued pressure. However, the stock appears dramatically undervalued, with a DCF‑derived fair value of $360.73 and an upside potential of roughly 78%, while its forward PE of 8.35 is well below the industry average of 16.57. Fundamentally, GBLI delivers a solid dividend yield of 5.09% with an 80% payout ratio, a low beta of 0.24, and a price‑to‑book of 0.56, suggesting a value‑oriented profile. The latest earnings release highlighted improving underwriting performance – the combined ratio fell to 92.2% and Q4 underwriting profit rose to $11 million – yet Q4 EPS missed estimates (reported $0.41 vs. $0.89 expected), introducing short‑term earnings volatility. Cash generation is strong, with free cash flow of $270 million dwarfing dividend obligations, and the balance sheet shows modest debt ($8.3 million) relative to equity. Overall, the stock trades at a discount to peers, offers attractive income, but faces bearish technical momentum and liquidity constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators and price near support
  • Decreasing volume indicating limited short‑term buying interest
  • High dividend yield provides some cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (DCF fair value vs. market price)
  • Improving underwriting profitability and strong cash flow
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive sector positioning
  • Long‑term cash generation capacity and modest debt load
  • Potential for price re‑rating as market recognizes undervaluation

Key Metrics & Analysis

Financial Health

Revenue Growth7.90%
Profit Margin5.63%
P/E Ratio15.7
ROE3.63%
ROA1.21%
Debt/Equity1.18
P/B Ratio0.6
Op. Cash Flow$9.1M
Free Cash Flow$270.7M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI43.0
Support$26.91
Resistance$30.00
MA 20$28.32
MA 50$28.40
MA 200$29.12
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Fair Value$360.73
Target Price$49.00
Upside/Downside77.86%
GradeUndervalued
TypeValue
Dividend Yield5.09%

Risk Assessment

Beta0.24
Volatility23.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.